These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
780 related articles for article (PubMed ID: 35806089)
1. Flagellotropic Bacteriophages: Opportunities and Challenges for Antimicrobial Applications. Esteves NC; Scharf BE Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806089 [TBL] [Abstract][Full Text] [Related]
2. The multi-drug efflux system AcrABZ-TolC is essential for infection of Esteves NC; Porwollik S; McClelland M; Scharf BE J Virol; 2021 May; 95(11):. PubMed ID: 33731456 [TBL] [Abstract][Full Text] [Related]
3. More than Rotating Flagella: Lipopolysaccharide as a Secondary Receptor for Flagellotropic Phage 7-7-1. Gonzalez F; Helm RF; Broadway KM; Scharf BE J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012730 [TBL] [Abstract][Full Text] [Related]
4. Phages on filaments: A genetic screen elucidates the complex interactions between Salmonella enterica flagellin and bacteriophage Chi. Esteves NC; Bigham DN; Scharf BE PLoS Pathog; 2023 Aug; 19(8):e1011537. PubMed ID: 37535496 [TBL] [Abstract][Full Text] [Related]
5. Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria. Almeida GMF; Laanto E; Ashrafi R; Sundberg LR mBio; 2019 Nov; 10(6):. PubMed ID: 31744913 [TBL] [Abstract][Full Text] [Related]
6. Flagellotropic phages: common yet diverse host interaction strategies. Gambino M; Sørensen MCH Curr Opin Microbiol; 2024 Apr; 78():102451. PubMed ID: 38452595 [TBL] [Abstract][Full Text] [Related]
7. [Phage therapy, an additional strategy against multidrug-resistant bacteria]. Boniver M; Wotquenne P; Moutschen M; Rousseau AF Rev Med Liege; 2022 Sep; 77(9):510-515. PubMed ID: 36082597 [TBL] [Abstract][Full Text] [Related]
8. Campylobacter jejuni motility is required for infection of the flagellotropic bacteriophage F341. Baldvinsson SB; Sørensen MC; Vegge CS; Clokie MR; Brøndsted L Appl Environ Microbiol; 2014 Nov; 80(22):7096-106. PubMed ID: 25261508 [TBL] [Abstract][Full Text] [Related]
9. The disparate effects of bacteriophages on antibiotic-resistant bacteria. Torres-Barceló C Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018 [TBL] [Abstract][Full Text] [Related]
10. Virulence-associated factors as targets for phage infection. de Melo AG; Morency C; Moineau S Curr Opin Microbiol; 2024 Jun; 79():102471. PubMed ID: 38569419 [TBL] [Abstract][Full Text] [Related]
12. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going? Luong T; Salabarria AC; Roach DR Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528 [TBL] [Abstract][Full Text] [Related]
16. Evolutionary Rationale for Phages as Complements of Antibiotics. Torres-Barceló C; Hochberg ME Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863 [TBL] [Abstract][Full Text] [Related]
17. A game of resistance: War between bacteria and phages and how phage cocktails can be the solution. Costa P; Pereira C; Romalde JL; Almeida A Virology; 2024 Nov; 599():110209. PubMed ID: 39186863 [TBL] [Abstract][Full Text] [Related]
18. fENko-Kae01 is a flagellum-specific jumbo phage infecting Klebsiella aerogenes. Ranta K; Skurnik M; Kiljunen S BMC Microbiol; 2024 Jul; 24(1):234. PubMed ID: 38951769 [TBL] [Abstract][Full Text] [Related]
19. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences. Chanishvili N Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies. Dąbrowska K; Abedon ST Microbiol Mol Biol Rev; 2019 Nov; 83(4):. PubMed ID: 31666296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]